Supplementary Effect of Choline Alfoscerate on Speech Recognition in Patients With Age-Related Hearing Loss: A Prospective Study in 34 Patients (57 Ears).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.3389\/fnagi.2021.684519<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC8211767?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1097\/md.0000000000038067<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11175912?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.2147\/dddt.s193424<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.dovepress.com\/getfile.php?fileID=48933<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Effect of Choline Alfoscerate on the Progression From Mild Cognitive Impairment to Dementia: Distributed Network Analysis of a Multicenter Korean Database Using a Common Data Model.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.12779\/dnd.2024.23.4.202<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11538851?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Potential Risk of Choline Alfoscerate on Isoflurane-Induced Toxicity in Primary Human Astrocytes.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.3340\/jkns.2023.0208<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jkns.or.kr\/upload\/pdf\/jkns-2023-0208.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Effect of Choline Alfoscerate on Cognitive Dysfunction After Mild Traumatic Brain Injury: A Single-Center Prospective Case-Control Study.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.13004\/kjnt.2025.21.e17<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12062814?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Age-related structural changes in the rat cerebellar cortex: effect of choline alfoscerate treatment.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1016\/0047-6374(91)90015-r<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Choi JJ<\/author><author>Hwang JS<\/author><author>Shin YJ<\/author><\/authors><\/contributors><titles><title>Effect of Oral Choline Alfoscerate on Patients with Keratoconjunctivitis Sicca.<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3390\/nu12051526<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/12\/5\/1526\/pdf?version=1590652841<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim DH<\/author><author>Seo YJ<\/author><\/authors><\/contributors><titles><title>Combination Therapy of Choline Alfoscerate With Ginkgo biloba Monotherapy in Age-Related Hearing Loss: Effects and Outcomes.<\/title><secondary-title>Journal of audiology & otology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.7874\/jao.2023.00192<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11810453?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3389\/fphar.2020.00232<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.00232\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Shavlovskaya OA<\/author><\/authors><\/contributors><titles><title>[Choline alfoscerate in the treatment of cognitive impairment].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.17116\/jnevro202612604148<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Pharmaceutical Formulation Containing Choline Alfoscerate<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>PHARMACEUTICAL FORMULATION CONTAINING CHOLINE ALFOSCERATE<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim YH<\/author><author>Jeon N<\/author><author>Je NK<\/author><\/authors><\/contributors><titles><title>Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea.<\/title><secondary-title>Alzheimer's & dementia (New York, N. Y.)<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1002\/trc2.70019<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11694518?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Duong KL<\/author><author>Jung H<\/author><author>Lee HK et al.<\/author><\/authors><\/contributors><titles><title>Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance.<\/title><secondary-title>BMC geriatrics<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1186\/s12877-024-05531-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11566286?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jun Cao<\/author><author>Erzheng Su<\/author><\/authors><\/contributors><titles><title>Unlocking the potential of <scp>l<\/scp> \u2010\u03b1\u2010glycerylphosphorylcholine in the food industry: From safety approvals to market prospects<\/title><secondary-title>Comprehensive Reviews in Food Science and Food Safety<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1111\/1541-4337.70117<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/1541-4337.70117<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Lee W<\/author><author>Kim M<\/author><\/authors><\/contributors><titles><title>Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.<\/title><secondary-title>Medicine<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1097\/MD.0000000000038067<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1097\/md.0000000000038067<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sohn M<\/author><author>Park YH<\/author><author>Lim S<\/author><\/authors><\/contributors><titles><title>Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.<\/title><secondary-title>Diabetes, obesity & metabolism<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1111\/dom.16131<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/dom.16131<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fleishhacker F<\/author><author>Bonfanti A<\/author><author>Granata N et al.<\/author><\/authors><\/contributors><titles><title>Choline Alfoscerate in the Treatment of Subthreshold Depression in the Elderly: A Pilot Study (CARTESIO).<\/title><secondary-title>Journal of clinical medicine<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/jcm15114037<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13258180?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.17116\/oftalma2016132273-76<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.17116\/oftalma2016132273-76<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>et al.<\/author><\/authors><\/contributors>Supplementary Effect of Choline Alfoscerate on Speech Recognition in Patients With Age-Related Hearing Loss: A Prospective Study in 34 Patients (57 Ears).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.3389\/fnagi.2021.684519<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC8211767?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1097\/md.0000000000038067<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11175912?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.2147\/dddt.s193424<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.dovepress.com\/getfile.php?fileID=48933<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Effect of Choline Alfoscerate on the Progression From Mild Cognitive Impairment to Dementia: Distributed Network Analysis of a Multicenter Korean Database Using a Common Data Model.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.12779\/dnd.2024.23.4.202<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11538851?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Potential Risk of Choline Alfoscerate on Isoflurane-Induced Toxicity in Primary Human Astrocytes.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.3340\/jkns.2023.0208<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jkns.or.kr\/upload\/pdf\/jkns-2023-0208.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Effect of Choline Alfoscerate on Cognitive Dysfunction After Mild Traumatic Brain Injury: A Single-Center Prospective Case-Control Study.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.13004\/kjnt.2025.21.e17<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12062814?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Age-related structural changes in the rat cerebellar cortex: effect of choline alfoscerate treatment.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1016\/0047-6374(91)90015-r<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Choi JJ<\/author><author>Hwang JS<\/author><author>Shin YJ<\/author><\/authors><\/contributors><titles><title>Effect of Oral Choline Alfoscerate on Patients with Keratoconjunctivitis Sicca.<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3390\/nu12051526<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/12\/5\/1526\/pdf?version=1590652841<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim DH<\/author><author>Seo YJ<\/author><\/authors><\/contributors><titles><title>Combination Therapy of Choline Alfoscerate With Ginkgo biloba Monotherapy in Age-Related Hearing Loss: Effects and Outcomes.<\/title><secondary-title>Journal of audiology & otology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.7874\/jao.2023.00192<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11810453?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3389\/fphar.2020.00232<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.00232\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Shavlovskaya OA<\/author><\/authors><\/contributors><titles><title>[Choline alfoscerate in the treatment of cognitive impairment].<\/title><secondary-title>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.17116\/jnevro202612604148<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Pharmaceutical Formulation Containing Choline Alfoscerate<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>PHARMACEUTICAL FORMULATION CONTAINING CHOLINE ALFOSCERATE<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kim YH<\/author><author>Jeon N<\/author><author>Je NK<\/author><\/authors><\/contributors><titles><title>Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea.<\/title><secondary-title>Alzheimer's & dementia (New York, N. Y.)<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1002\/trc2.70019<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11694518?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Duong KL<\/author><author>Jung H<\/author><author>Lee HK et al.<\/author><\/authors><\/contributors><titles><title>Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance.<\/title><secondary-title>BMC geriatrics<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1186\/s12877-024-05531-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC11566286?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jun Cao<\/author><author>Erzheng Su<\/author><\/authors><\/contributors><titles><title>Unlocking the potential of <scp>l<\/scp> \u2010\u03b1\u2010glycerylphosphorylcholine in the food industry: From safety approvals to market prospects<\/title><secondary-title>Comprehensive Reviews in Food Science and Food Safety<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1111\/1541-4337.70117<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/1541-4337.70117<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Lee W<\/author><author>Kim M<\/author><\/authors><\/contributors><titles><title>Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.<\/title><secondary-title>Medicine<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1097\/MD.0000000000038067<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1097\/md.0000000000038067<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sohn M<\/author><author>Park YH<\/author><author>Lim S<\/author><\/authors><\/contributors><titles><title>Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.<\/title><secondary-title>Diabetes, obesity & metabolism<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1111\/dom.16131<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/dom.16131<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fleishhacker F<\/author><author>Bonfanti A<\/author><author>Granata N et al.<\/author><\/authors><\/contributors><titles><title>Choline Alfoscerate in the Treatment of Subthreshold Depression in the Elderly: A Pilot Study (CARTESIO).<\/title><secondary-title>Journal of clinical medicine<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/jcm15114037<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13258180?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.17116\/oftalma2016132273-76<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.17116\/oftalma2016132273-76<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"